Epinephrine – Warning Risk for Serious or Fatal Medication Errors

Please note this urgent message from the National Alert Network (NAN) for Serious Medication Errors.   The National Council for Medication Error Reporting and Prevention (NCCMERP) is distributing a NAN alert to warn practitioners about the potential for serious or fatal errors with epinephrine, caused by the current shortage of epinephrine emergency syringes. EPINEPHrine emergency syringes…

Need 411 on IO?

A few months ago, I blogged about intraosseous (IO) access – see  IO made easy.   This type of vascular access is experiencing tremendous growth and is beginning to gain acceptance as a true alternative access for infusion therapy. However, I think many nurses are still hesitant to consider IO access as a viable option for…

FDA Alert on certain IV medications

The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals not to use certain intravenous (IV) bags of metronidazole, ondansetron, and ciprofloxacin because of potential contamination. FDA has received reports of floating matter in IV bags manufactured by Claris Lifesciences Limited, in Ahmedabad, India. Microbiological analysis identified the matter in one of the bags…

Informed consent for Infusions of Biologics

A common question I get asked by nurses is…..do I need to obtained an  informed consent from a patient who is receiving infusions of biologic agents such as  Remicade (Infliximab)? An informed consent, according to the American Medical Association (AMA), is the communication process between a patient and his or her physician that results in…

Infusions of Monoclonal Antibodies in New York State

In the past 12 years, we have seen an increase in new monoclonal antibodies approved by the FDA for numerous indications as treatment options for cancer, neurologic disorders, immunologic,  and autoimmune diseases, to name a few. These monoclonal antibodies are administered either subcutaneously, usually self administered by patients or administered intravenously by a registered nurse…

Recall: IV Extension Sets with BD Q-Syte™ Luer Access Device

An FDA press release stated that Acacia Inc. voluntarily executed a product recall of certain lots of IV Extension Sets with BD Q-Syte™ Luer Access Device.   The BD Q-Syte™ Luer Access Device is a Needleless Valve manufactured by BD (Becton, Dickinson and Company). The IV Extension Set with BD Q-Syte™ Luer Access device is intended…